IN RE: MARCO GULDENAAR HOLDINGS B.V.
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Federal Circuit Summary
Before Chen, Mayer, and Bryson. Appeal from the Patent Trial and Appeal Board.
Summary: Claims directed to the abstract idea of rules for playing a dice game are not transformed into patent eligible subject matter by the addition of printed matter.
The patent examiner rejected the application at issue under § 101, because the claims were directed to the abstract idea of rules for playing a dice game. The PTAB and then the Federal Circuit affirmed. The Federal Circuit previously held, in In re Smith, 815 f .3d 816 (Fed. Cir. 2016), that a “method of conducting a wagering game” using a deck of playing cards was an abstract idea. Similarly, the claims here were directed towards the abstract idea of a wagering game, but with dice. The Applicant argued that the claimed dice markings were novel and not abstract. The Federal Circuit rejected that argument because the dice markings constituted “printed matter,” which information is not patent eligible subject matter and is outside the scope of § 101. Without an “inventive concept” the claimed subject matter is not patent eligible.
Judge Mayer concurred in the judgment but wrote separately to state that: (1) the § 101 analysis is a pure question of law; and (2) claims directed to dice, card, and board games are not patent eligible because they endeavor to influence human behavior rather than effect technological change.
This case is: IN RE: MARCO GULDENAAR HOLDINGS B.V.
Edited by: Paul Stewart
Written by: Samuel I. Cockriel and Mark Kachner
More insights
Fresh From the Bench: Latest Precedential Patent Case
Ridge Corp. et al. v. Kirk NationaLease Co. et al. , Appeal No. 2025-1254 (Fed. Cir. July 13, 2026) In its only precedential patent opinion last week, the Federal Circuit considered an appeal of a preliminary injunction issued by the U.S. District Court…
Fresh From the Bench: Latest Precedential Patent Cases
CASE OF THE WEEK Wyeth LLC v. AstraZeneca Pharmaceuticals LP , Appeal No. 2024-2325 (Fed. Cir. July 9, 2026) In our Case of the Week, the Federal Circuit affirmed a district court ruling reversing a $107.5 million jury verdict against AstraZeneca in a case…
Enanta Pharmaceuticals, Inc. v. Pfizer Inc., Appeal No. 2025-1427 (Fed. Cir. Jun. 23, 2026)
CASE OF THE WEEK Enanta Pharmaceuticals, Inc. v. Pfizer Inc., Appeal No. 2025-1427 (Fed. Cir. Jun. 23, 2026) In our Case of the Week, the Federal Circuit affirmed summary judgment invalidating all claims of Enanta’s Patent No. 11,358,953 as…